XBIO
Xenetic Biosciences, Inc.
Company overview
- Market capitalization
- $5.46M
- Employees
- 2
- Latest publication
- 2026-09-29
About Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 660,601USD | 806,923USD | 766,296USD | 1,026,956USD | 589,897USD | 593,261USD | 648,820USD | 614,243USD |
| Research Development | 552,013USD | 661,443USD | 773,416USD | 756,482USD | 656,557USD | 879,029USD | 1,042,255USD | 367,985USD |
| General And Administrative Expenses | 1,080,278USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 1,632,291USD | 1,309,040USD | 1,389,323USD | 1,571,690USD | 1,314,309USD | 1,535,670USD | 1,747,965USD | 1,113,716USD |
| Operating Income | -971,690USD | -502,117USD | -623,027USD | -544,734USD | -724,412USD | -942,409USD | -1,099,145USD | -499,473USD |
| Total Other Income Expense Net | 41,995USD | 45,735USD | 43,951USD | 34,795USD | 35,709USD | 39,268USD | 44,624USD | 62,802USD |
| Interest Income | 42,067USD | 45,756USD | 43,792USD | 30,783USD | 34,232USD | 39,190USD | 51,867USD | 61,298USD |
| Net Income | -929,695USD | -456,382USD | -579,076USD | -509,939USD | -688,703USD | -903,141USD | -1,054,521USD | -436,671USD |
| Gross Profit | — | 806,923USD | 766,296USD | 1,026,956USD | 589,897USD | 593,261USD | 648,820USD | 614,243USD |
| Selling General Administrative | — | 647,597USD | 615,907USD | 815,209USD | 657,752USD | 656,641USD | 705,710USD | 745,731USD |
| Net Interest Income | — | 45,756USD | 43,792USD | 30,783USD | 34,232USD | 39,190USD | 51,867USD | 61,298USD |
| Income Before Tax | — | -456,382USD | -579,076USD | -509,939USD | -688,703USD | -903,141USD | -1,054,521USD | -436,671USD |
| Net Income From Continuing Ops | — | -456,382USD | -579,076USD | -509,940USD | -688,703USD | -903,141USD | -1,054,521USD | -436,671USD |
| Ebitda | — | -502,117USD | -623,027USD | -523,176USD | -724,412USD | -942,409USD | -1,099,145USD | -499,473USD |
| Ebit | — | — | — | -509,939USD | — | -1,109,769USD | — | — |
| Depreciation And Amortization | — | — | — | -13,237USD | — | 10,624USD | — | — |
| Income Tax Expense | — | — | — | — | — | -10,624USD | — | -436,671USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,976,411USD | 2,500,284USD | 2,539,986USD | 1,706,925USD | 1,160,692USD | 436,942USD | 17,066USD | 0USD |
| Gross Profit | 2,976,411USD | 2,500,284USD | 2,539,986USD | 1,706,925USD | 1,160,692USD | 436,942USD | 17,066USD | -15,827USD |
| Research Development | 3,065,484USD | 3,288,332USD | 3,494,765USD | 4,770,834USD | 3,163,485USD | 1,731,406USD | 4,889,340USD | 2,883,952USD |
| Selling General Administrative | 2,745,509USD | 3,416,380USD | 3,560,936USD | 3,653,999USD | 3,743,972USD | 3,400,071USD | 4,731,176USD | 4,392,375USD |
| Total Operating Expenses | 5,810,993USD | 6,704,712USD | 7,055,701USD | 8,424,833USD | 6,907,457USD | 14,374,605USD | 12,903,895USD | 7,276,327USD |
| Operating Income | -2,834,582USD | -4,204,428USD | -4,515,715USD | -6,717,908USD | -5,746,765USD | -13,937,663USD | -12,886,829USD | -7,276,327USD |
| Interest Income | 147,997USD | 249,861USD | 351,807USD | 167,152USD | 100,467USD | 126,171USD | 108,490USD | 510USD |
| Net Interest Income | 147,997USD | 249,861USD | 351,807USD | 167,152USD | 100,467USD | 126,171USD | 108,489USD | 509USD |
| Income Before Tax | -2,680,860USD | -3,960,275USD | -4,134,578USD | -6,552,353USD | -5,645,179USD | -13,811,984USD | -12,775,025USD | -7,300,458USD |
| Net Income | -2,680,860USD | -3,960,275USD | -4,134,578USD | -6,552,353USD | -5,645,179USD | -10,893,466USD | -12,775,025USD | -7,300,458USD |
| Net Income From Continuing Ops | -2,680,860USD | -3,960,275USD | -4,445,607USD | -6,552,353USD | -5,645,179USD | -10,893,466USD | -12,775,025USD | -7,300,458USD |
| Ebitda | -2,834,582USD | -4,051,092USD | -4,515,715USD | -6,690,865USD | -5,711,283USD | -4,665,698USD | -9,575,963USD | -7,260,500USD |
| Total Other Income Expense Net | 153,722USD | 244,153USD | 381,137USD | 165,555USD | 101,586USD | 125,679USD | 111,804USD | -24,131USD |
| Ebit | — | -4,204,428USD | -4,487,792USD | -6,717,908USD | -5,746,765USD | -4,694,535USD | -9,603,450USD | -7,276,327USD |
| Depreciation And Amortization | — | 153,336USD | -28,208USD | 27,043USD | 35,482USD | 28,837USD | 27,487USD | 15,827USD |
| Income Tax Expense | — | — | 28,207USD | -165,555USD | -100,467USD | -2,918,518USD | 3,174,890USD | 24,131USD |
| Reconciled Depreciation | — | — | 0USD | 27,043USD | 35,482USD | 28,837USD | 27,487USD | 15,827USD |
| Cost Of Revenue | — | — | — | 27,043USD | 35,482USD | — | — | 15,827USD |
| Interest Expense | — | — | — | 165,555USD | 101,586USD | 18,360,577USD | 111,804USD | 24,131USD |
| Tax Provision | — | — | — | — | 0USD | -2,918,518USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -5,645,179USD | -10,893,466USD | -18,059,404USD | -7,300,458USD |
| Unclassified Operating Expenses | — | — | — | — | — | 9,243,128USD | 3,283,379USD | — |
| Non Operating Income Net Other | — | — | — | — | — | -492USD | 3,315USD | -24,640USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 6,967,998USD | 7,908,991USD | 8,363,847USD | 5,067,960USD | 5,353,700USD | 5,791,217USD | 6,901,443USD | 8,046,000USD |
| Cash And Equivalents | 6,471,766USD | — | — | — | — | — | — | — |
| Total Current Assets | 6,654,077USD | 7,595,070USD | 8,049,926USD | 5,067,960USD | 5,353,700USD | 5,477,296USD | 6,587,522USD | 7,027,648USD |
| Other Current Assets | 182,311USD | 247,815USD | 166,294USD | 946,361USD | 573,854USD | 313,620USD | 421,954USD | 188,088USD |
| Other Non Current Assets | 313,921USD | — | — | — | — | — | — | — |
| Total Liabilities | 894,977USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 894,977USD | 958,239USD | 968,025USD | 1,111,775USD | 903,430USD | 667,927USD | 894,263USD | 1,009,407USD |
| Total Stockholder Equity | 6,073,021USD | 6,950,752USD | 7,395,822USD | 3,956,185USD | 4,450,270USD | 5,123,290USD | 6,007,180USD | 7,036,593USD |
| Total Equity Including Noncontrolling Interest | 6,073,021USD | — | — | — | — | — | — | — |
| Accounts Payable | 322,537USD | 558,808USD | 258,109USD | 578,250USD | 346,828USD | 240,293USD | 283,615USD | 243,343USD |
| Common Stock | 2,346USD | 2,294USD | 2,294USD | 1,545USD | 1,545USD | 1,545USD | 1,545USD | 1,545USD |
| Retained Earnings | -201,261,408USD | -200,331,713USD | -199,875,331USD | -199,296,255USD | -198,786,315USD | -198,097,612USD | -197,194,471USD | -196,139,950USD |
| Accumulated Other Comprehensive Income | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD |
| Total Liab | — | 958,239USD | 968,025USD | 1,111,775USD | 903,430USD | 667,927USD | 894,263USD | 1,009,407USD |
| Other Current Liab | — | 399,431USD | 709,916USD | 533,525USD | 556,602USD | 427,634USD | 610,648USD | 766,064USD |
| Capital Stock | — | 3,748USD | 3,748USD | 3,349USD | 3,349USD | 3,349USD | 3,349USD | 3,349USD |
| Cash | — | 7,347,255USD | 7,883,632USD | 4,121,599USD | 4,779,846USD | 5,163,676USD | 6,165,568USD | 6,839,560USD |
| Cash And Short Term Investments | — | 7,347,255USD | 7,883,632USD | 4,121,599USD | 4,779,846USD | 5,163,676USD | 6,165,568USD | 6,839,560USD |
| Net Debt | — | -7,347,255USD | -7,883,632USD | -4,121,599USD | -4,779,846USD | -5,163,676USD | -6,165,568USD | -6,839,560USD |
| Common Stock Shares Outstanding | — | 2,291,056shares | 2,291,056shares | 1,542,139shares | 1,542,139shares | 1,542,139shares | 1,541,339shares | 1,541,722shares |
| Non Current Assets Total | — | 313,921USD | 313,921USD | 0USD | 0USD | 313,921USD | 313,921USD | 1,018,352USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 313,921USD | 313,921USD | — | — | 313,921USD | 313,921USD | 1,018,352USD |
| Net Working Capital | — | 6,636,831USD | 7,081,901USD | 3,956,185USD | 4,450,270USD | 4,809,369USD | 5,693,259USD | 6,018,241USD |
| Unclassified Equity | — | 207,022,689USD | 207,011,377USD | 202,993,812USD | 202,977,957USD | 202,962,274USD | 202,943,023USD | 202,917,915USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,363,847USD | 6,901,443USD | 10,605,226USD | 14,720,290USD | 19,815,360USD | 13,179,495USD | 21,546,926USD | 14,431,094USD |
| Other Current Assets | 166,294USD | 421,954USD | 603,828USD | 556,094USD | 479,399USD | 841,958USD | 722,079USD | 622,366USD |
| Total Liab | 968,025USD | 894,263USD | 809,585USD | 1,073,156USD | 1,421,103USD | 963,971USD | 4,333,675USD | 4,518,306USD |
| Total Stockholder Equity | 7,395,822USD | 6,007,180USD | 9,795,641USD | 13,647,134USD | 18,394,257USD | 12,215,524USD | 17,213,251USD | 9,912,788USD |
| Other Current Liab | 709,916USD | 610,648USD | 568,753USD | 785,796USD | 1,031,590USD | 574,050USD | 463,987USD | 665,641USD |
| Common Stock | 2,294USD | 1,545USD | 1,544USD | 1,520USD | 13,465USD | 8,771USD | 6,092USD | 9,726USD |
| Capital Stock | 3,748USD | 3,349USD | 3,348USD | 17,966USD | 16,239USD | 11,545USD | 8,866USD | 12,500USD |
| Retained Earnings | -199,875,331USD | -197,194,471USD | -193,234,196USD | -189,099,618USD | -182,547,265USD | -176,902,086USD | -166,008,620USD | -153,233,595USD |
| Cash | 7,883,632USD | 6,165,568USD | 8,983,046USD | 13,097,265USD | 18,244,030USD | 11,527,552USD | 10,367,920USD | 571,605USD |
| Cash And Short Term Investments | 7,883,632USD | 6,165,568USD | 8,983,046USD | 13,097,265USD | 18,244,030USD | 11,527,552USD | 10,367,920USD | 571,605USD |
| Total Current Assets | 8,049,926USD | 6,587,522USD | 9,586,874USD | 13,653,359USD | 18,723,429USD | 12,369,510USD | 11,089,999USD | 1,193,971USD |
| Total Current Liabilities | 968,025USD | 894,263USD | 809,585USD | 1,073,156USD | 1,421,103USD | 936,928USD | 1,415,157USD | 1,599,788USD |
| Net Debt | -7,883,632USD | -6,165,568USD | -8,983,046USD | -13,097,265USD | -18,216,987USD | -11,465,027USD | -10,347,878USD | -571,605USD |
| Accounts Payable | 258,109USD | 283,615USD | 240,832USD | 287,360USD | 362,470USD | 327,396USD | 931,128USD | 934,147USD |
| Accumulated Other Comprehensive Income | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD | 253,734USD |
| Common Stock Shares Outstanding | 1,701,571shares | 1,541,339shares | 1,528,210shares | 1,422,443shares | 1,027,940shares | 639,238shares | 285,246shares | 75,601shares |
| Non Current Assets Total | 313,921USD | 313,921USD | 1,018,352USD | 1,066,931USD | 1,091,931USD | 809,985USD | 10,456,926USD | 13,237,123USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 287,360USD | 362,470USD | 27,043USD | 2,918,518USD | 2,918,518USD |
| Non Currrent Assets Other | 313,921USD | 313,921USD | 1,018,352USD | 1,066,931USD | 1,091,931USD | 782,942USD | 1,192,999USD | 705,660USD |
| Net Working Capital | 7,081,901USD | 5,693,259USD | 8,777,289USD | 12,580,203USD | 17,302,326USD | 11,432,582USD | 9,674,842USD | -405,817USD |
| Unclassified Equity | 207,011,377USD | 202,943,023USD | 202,771,211USD | 202,473,532USD | 200,658,084USD | 194,124,740USD | 188,234,359USD | 168,151,603USD |
| Other Assets | — | — | — | — | 1,091,931USD | 809,985USD | 1,213,042USD | 705,660USD |
| Current Deferred Revenue | — | — | — | — | -27,043USD | -35,482USD | -20,042USD | — |
| Short Term Debt | — | — | — | — | 27,043USD | 35,482USD | 20,042USD | — |
| Short Long Term Debt Total | — | — | — | — | 27,043USD | 62,525USD | 20,042USD | — |
| Property Plant Equipment Net | — | — | — | — | 0USD | 27,043USD | 20,799USD | 4,956USD |
| Property Plant Equipment Gross | — | — | — | — | 50,243USD | 57,027USD | 57,027USD | — |
| Net Tangible Assets | — | — | — | — | 18,391,483USD | 12,212,750USD | 7,967,349USD | -2,616,493USD |
| Unclassified Non Current Assets | — | — | — | — | -1,091,931USD | — | -10,456,170USD | — |
| Deferred Long Term Liab | — | — | — | — | — | 27,043USD | 2,918,518USD | 2,918,518USD |
| Other Liab | — | — | — | — | — | 27,043USD | 2,918,518USD | 2,918,518USD |
| Good Will | — | — | — | — | — | 0USD | 9,243,128USD | 3,283,379USD |
| Net Receivables | — | — | — | — | — | 500,000USD | — | — |
| Treasury Stock | — | — | — | — | — | -5,281,180USD | -5,281,180USD | -5,281,180USD |
| Non Current Liabilities Other | — | — | — | — | — | 27,043USD | — | — |
| Intangible Assets | — | — | — | — | — | — | 9,243,128USD | 9,243,128USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | -2,918,518USD | -2,918,518USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -456,382USD | -579,076USD | -509,939USD | -688,703USD | -903,141USD | -1,054,521USD | -436,671USD | -1,273,970USD |
| Stock Based Compensation | 11,312USD | 13,998USD | 15,855USD | 15,683USD | 19,251USD | 25,108USD | 27,536USD | 42,096USD |
| Other Non Cash Items | 11,312USD | 322,396USD | 15,854USD | 171,190USD | 19,251USD | — | 615,562USD | -829,012USD |
| Change In Working Capital | -91,307USD | 322,396USD | -164,162USD | 289,190USD | -118,002USD | 355,421USD | -49,902USD | 706,770USD |
| Total Cash From Operating Activities | -536,377USD | -242,682USD | -658,247USD | -383,830USD | -1,001,892USD | -673,992USD | -459,037USD | -525,104USD |
| Capital Expenditures | -3USD | 0USD | -3USD | 0USD | -2USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -536,380USD | -242,682USD | -658,250USD | -383,830USD | -1,001,890USD | -673,992USD | -459,037USD | -525,104USD |
| Change In Cash | -536,377USD | 3,762,033USD | -658,247USD | -383,830USD | -1,001,892USD | -673,992USD | -459,037USD | -525,104USD |
| Begin Period Cash Flow | 7,883,632USD | 4,121,599USD | 4,779,846USD | 5,163,676USD | 6,165,568USD | 6,839,560USD | 7,298,597USD | 7,823,701USD |
| End Period Cash Flow | 7,347,255USD | 7,883,632USD | 4,121,599USD | 4,779,846USD | 5,163,676USD | 6,165,568USD | 6,839,560USD | 7,298,597USD |
| Total Cash From Financing Activities | — | 4,004,715USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | 4,004,715USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,680,860USD | -3,960,275USD | -4,134,578USD | -6,552,353USD | -5,645,179USD | -10,893,466USD | -12,775,025USD | -7,300,458USD |
| Stock Based Compensation | 64,787USD | 171,814USD | 283,085USD | 511,480USD | 410,437USD | 468,914USD | 853,517USD | 1,421,581USD |
| Other Non Cash Items | 329,422USD | 970,983USD | 283,085USD | 1,793,750USD | 24,269USD | 9,099,489USD | 6,376,141USD | -5,231USD |
| Change In Working Capital | 329,422USD | 970,983USD | -262,726USD | -426,685USD | 461,193USD | -52,449USD | -881,524USD | -595,676USD |
| Total Cash From Operating Activities | -2,286,651USD | -2,817,478USD | -4,114,219USD | -4,646,765USD | -4,738,067USD | -4,267,193USD | -6,399,404USD | -6,463,957USD |
| Capital Expenditures | 0USD | 0USD | -1USD | -500,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -2,286,651USD | -2,817,478USD | -4,114,220USD | -5,146,765USD | -4,738,067USD | -4,267,193USD | -6,399,404USD | -6,463,957USD |
| Total Cash From Financing Activities | 4,004,715USD | 1USD | 16USD | 1,293,750USD | 11,454,545USD | 5,426,825USD | 16,127,209USD | 1,480,000USD |
| Issuance Of Capital Stock | 4,004,715USD | 1USD | — | 0USD | 11,450,866USD | 5,426,825USD | 16,121,000USD | — |
| Change In Cash | 1,718,064USD | -2,817,478USD | -4,114,219USD | -5,146,765USD | 6,716,478USD | 1,159,632USD | 9,729,805USD | -4,961,457USD |
| Begin Period Cash Flow | 6,165,568USD | 8,983,046USD | 13,097,265USD | 18,244,030USD | 11,527,552USD | 10,367,920USD | 638,115USD | 5,599,572USD |
| End Period Cash Flow | 7,883,632USD | 6,165,568USD | 8,983,046USD | 13,097,265USD | 18,244,030USD | 11,527,552USD | 10,367,920USD | 638,115USD |
| Other Cashflows From Financing Activities | 4,004,715USD | — | -16USD | -500,000USD | 3,679USD | 5,426,825USD | 6,209USD | 1,480,000USD |
| Unclassified Financing Cash Flow | -4,004,715USD | — | — | — | — | -5,426,825USD | 13,089,774USD | -1,480,000USD |
| Depreciation | — | — | 0USD | 27,043USD | 35,482USD | 28,837USD | 27,487USD | 15,827USD |
| Investments | — | — | 0USD | -500,000USD | 0USD | 0USD | 2,000USD | 22,500USD |
| Total Cashflows From Investing Activities | — | — | — | -500,000USD | — | — | 2,000USD | 22,500USD |
| Sale Purchase Of Stock | — | — | — | 1,293,750USD | — | 5,426,825USD | 3,031,226USD | 1,480,000USD |
| Other Cashflows From Investing Activities | — | — | — | 500,000USD | — | — | 2,000USD | 22,500USD |
| Change To Liabilities | — | — | — | — | 457,132USD | -378,111USD | -227,961USD | -343,878USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 1,159,632USD | 9,729,805USD | -4,961,457USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | -2,918,518USD | — | — |
| Change To Account Receivables | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2019Yearly · 2019-12-31 | Product | Codevelopment Agr | 0 | USD | 0001683168-20-000967 |
| FY 2019Yearly · 2019-12-31 | Product | Royalty | 17,066 | USD | 0001683168-20-000967 |
| FY 2019Yearly · 2019-12-31 | Product | Royalty Revenue | 0 | USD | 0001683168-20-000967 |
| FY 2017Yearly · 2017-12-31 | Product | Codevelopment Agr | 0 | USD | 0001683168-19-000840 |
| FY 2017Yearly · 2017-12-31 | Product | License | 7,500,000 | USD | 0001683168-19-000840 |
| FY 2017Yearly · 2017-12-31 | Product | Royalty Revenue | 0 | USD | 0001683168-19-000840 |
| FY 2017Yearly · 2017-12-31 | Product | Services | 85,000 | USD | 0001683168-19-000840 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.